<SEC-DOCUMENT>0001213900-25-106675.txt : 20251105
<SEC-HEADER>0001213900-25-106675.hdr.sgml : 20251105
<ACCEPTANCE-DATETIME>20251105163051
ACCESSION NUMBER:		0001213900-25-106675
CONFORMED SUBMISSION TYPE:	F-3/A
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20251105
DATE AS OF CHANGE:		20251105

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Brenmiller Energy Ltd.
		CENTRAL INDEX KEY:			0001901215
		STANDARD INDUSTRIAL CLASSIFICATION:	HEATING EQUIPMENT, EXCEPT ELECTRIC & WARM AIR FURNACES [3433]
		ORGANIZATION NAME:           	04 Manufacturing
		EIN:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		F-3/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-290642
		FILM NUMBER:		251454545

	BUSINESS ADDRESS:	
		STREET 1:		13 AMAL STREET
		CITY:			ROSH HAAYIN
		STATE:			L3
		ZIP:			4809249
		BUSINESS PHONE:		972776935140

	MAIL ADDRESS:	
		STREET 1:		13 AMAL STREET
		CITY:			ROSH HAAYIN
		STATE:			L3
		ZIP:			4809249
</SEC-HEADER>
<DOCUMENT>
<TYPE>F-3/A
<SEQUENCE>1
<FILENAME>ea0264155-f3a1_brenmiller.htm
<DESCRIPTION>AMENDMENT NO. 1 TO FORM F-3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <B>As filed with the Securities and Exchange
Commission on November 5, 2025</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"> <B>Registration No. 333-290642</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>WASHINGTON, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <B>AMENDMENT NO. 1</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <B>TO</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM F-3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REGISTRATION STATEMENT<BR>
UNDER THE SECURITIES ACT OF 1933</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>BRENMILLER
ENERGY LTD.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Not Applicable</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Translation of Registrant&rsquo;s Name into English)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%; border-bottom: black 1.5pt solid; text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>State of Israel</B></FONT></TD>
    <TD STYLE="width: 2%; text-align: center; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 49%; border-bottom: black 1.5pt solid; text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Not Applicable</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(State or other jurisdiction of<BR>
incorporation
or organization)</P></TD>
    <TD STYLE="text-align: center; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S. Employer<BR>
Identification No.)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>13 Amal St. 4<SUP>th</SUP> Floor, Park Afek</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Rosh Haayin</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>4809249 Israel</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>+972-77-6935140</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address and telephone number of registrant&rsquo;s
principal executive offices)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Brenmiller Energy U.S. Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>21 Morningside Dr.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Weatogue, CT 06089</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Tel: (646) 480-0290</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name, address, and telephone number of agent for
service)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Copies to:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Oded Har-Even, Esq.</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Eric Victorson, Esq.</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Sullivan &amp; Worcester LLP</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>1251 Avenue of the Americas</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>New York, NY 10020</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Tel: (212) 660-3000</B></P></TD>
    <TD STYLE="width: 50%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Reut Alfiah, Adv.</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Gal Cohen, Adv.</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Sullivan &amp; Worcester Tel Aviv (Har-Even
    &amp; Co.) </B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>28 HaArba&rsquo;a St. HaArba&rsquo;a Towers</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>North Tower, 35th floor</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Tel Aviv, Israel 6473925</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Tel: +972 74-758-0480</B></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Approximate date of commencement of proposed
sale to the public</B>: From time to time after the effective date of this Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If only securities being registered on this Form
are being offered pursuant to dividend or interest reinvestment plans, please check the following box. &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If any of the securities being registered on this
Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box.
&#9746;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is filed to register additional securities
for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration
statement number of the earlier effective registration statement for the same offering. &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is a post-effective amendment filed
pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of
the earlier effective registration statement for the same offering. &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is a registration statement pursuant
to General Instruction I.C. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant
to Rule 462(e) under the Securities Act, check the following box. &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is a post-effective amendment to
a registration statement filed pursuant to General Instruction I.C. filed to register additional securities or additional classes of securities
pursuant to Rule 413(b) under the Securities Act, check the following box. &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Emerging growth company &#9746;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company that prepares its
financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition
period for complying with any new or revised financial accounting standards&dagger; provided pursuant to Section 7(a)(2)(B) of the Securities
Act. &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&dagger;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
term &ldquo;new or revised financial accounting standard&rdquo; refers to any update issued by the Financial Accounting Standards Board
to its Accounting Standards Codification after April 5, 2012.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B>This registration statement shall hereafter
become effective in accordance with the provisions of Section 8(a) of the Securities Act of 1933.</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <B>&nbsp;</B> </P>

<P STYLE="text-align: justify; margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"> <B>If the Securities and Exchange Commission
resumes full operation before the Registration Statement becomes effective, we may file an amendment to this Registration Statement requesting
a delay or change in the effectiveness of the Registration Statement.</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#160;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <B>EXPLANATORY NOTE</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt 0; text-align: justify"> This Amendment No. 1 (&ldquo;Amendment No.
1&rdquo;) to the Registration Statement on <A HREF="http://www.sec.gov/Archives/edgar/data/1901215/000121390025094365/ea0259128-f3_brenmiller.htm">Form F-3</A> (Registration No. 333-290642)
of Brenmiller Energy Ltd. is being filed for the purpose of, <I>inter alia</I>, including language provided by Rule 473(b) of the Securities
Act of 1933, as amended, for the automatic effectiveness of this Registration Statement 20 days following the filing of Amendment No.
1. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="color: Red; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>The information in this
prospectus is not complete and may be changed. The selling shareholder may not sell these securities until the registration statement
filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities and
is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"> <FONT STYLE="color: Red"><B>Subject
to Completion, dated November 5, 2025</B></FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><B>PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B><IMG SRC="image_001.jpg" ALT=""></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>BRENMILLER ENERGY LTD.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>Up to 6,643,356 Ordinary
Shares</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus relates to
the resale, by the selling shareholder identified in this prospectus, of up to 6,643,356 ordinary shares, no par value per share, or the
Ordinary Shares, consisting of (i) 1,660,839 Ordinary Shares issuable upon the conversion of 3,800 preferred shares, with a conversion
price of $2.288 per share, or the Preferred Shares, (ii) up to an additional 1,660,839 Ordinary Shares issuable upon the conversion of
3,800 preferred shares, or the Additional Preferred Shares, reflecting 200% of the maximum number of shares issuable upon conversion of
the Preferred Shares, due to the potential effect of anti-dilution adjustments contained in the Preferred Shares (without taking into account any limitations on the conversion of such Preferred Shares set forth therein), (iii)
1,660,839 Ordinary Shares issuable upon the exercise of ordinary warrants, with an exercise price of $2.40 per share, or the Ordinary
Warrants and (iv) up to an additional 1,660,839 Ordinary Shares issuable upon exercise of ordinary warrants or, the Additional Ordinary
Warrants, and, together with the Ordinary Warrants, the Warrants,&nbsp;reflecting 200% of the maximum number of warrant shares issuable
upon exercise of the Warrants, due to the potential effect of anti-dilution adjustments contained in the Ordinary Warrants (without taking into account any limitations on the exercise of such Warrants set forth therein) (see &ldquo;<I>Our
Company&mdash;Recent Developments&mdash;July 2025 Private Placement</I>&rdquo; for additional information).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus describes
the general manner in which the Ordinary Shares may be offered and sold by the selling shareholder. If necessary, the specific manner
in which the Ordinary Shares may be offered and sold will be described in a prospectus supplement to this prospectus. No Ordinary Shares
are being registered hereunder for sale by us. We will not receive any proceeds from the sale of the Ordinary Shares by the selling shareholder,
however we will receive cash proceeds equal to the conversion price of any Preferred Shares that are converted to Ordinary Shares and
the exercise price of any Warrants that are exercised.&nbsp;See &ldquo;<I>Use of Proceeds</I>&rdquo;. The selling shareholder may sell
all or a portion of the Ordinary Shares from time to time in market transactions through any market on which our Ordinary Shares are then
traded, in negotiated transactions or otherwise, and at prices and on terms that will be determined by the then prevailing market price
or at negotiated prices directly or through a broker or brokers, who may act as agent or as principal or by a combination of such methods
of sale. See &ldquo;<I>Plan of Distribution</I>&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> Our Ordinary Shares are listed
on the Nasdaq Capital Market under the symbol &ldquo;BNRG.&rdquo; The last reported sale price of our Ordinary Shares on November 4,
2025 was $1.40 per share. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are an emerging growth
company, as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act, and a &ldquo;foreign private issuer&rdquo;, as
defined in Rule 405 under the U.S. Securities Act of 1933, as amended, or the Securities Act, and are eligible for reduced public company
reporting requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>AN
INVESTMENT IN OUR SECURITIES INVOLVES RISKS. SEE THE SECTION ENTITLED &ldquo;RISK FACTORS&rdquo; BEGINNING ON PAGE 4 AND IN OUR ANNUAL
REPORT ON FORM 20-F FOR THE FISCAL YEAR ENDED DECEMBER 31, 2024, which was filed on March 4, 2025, or the 2024 Annual Report.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Neither the Securities
and Exchange Commission, or the SEC, nor any state or other securities commission has approved or disapproved of these securities or determined
if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">The date of this prospectus
is &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="width: 90%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_001">OUR COMPANY</A></FONT></TD>
    <TD STYLE="width: 10%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_002">ABOUT THIS OFFERING</A></FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_003">RISK FACTORS</A></FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_004">NOTE REGARDING FORWARD-LOOKING STATEMENTS</A></FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</FONT></TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_005">USE OF PROCEEDS</A></FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_006">CAPITALIZATION</A></FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_007">SELLING SHAREHOLDERS</A></FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_008">PLAN OF DISTRIBUTION</A></FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</FONT></TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_009">LEGAL MATTERS</A></FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_010">EXPERTS</A></FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_011">EXPENSES</A></FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_012">ENFORCEABILITY OF CIVIL LIABILITIES</A></FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</FONT></TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_013">WHERE YOU CAN FIND ADDITIONAL INFORMATION</A></FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</FONT></TD></TR>
  <TR STYLE="background-color: white">
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a_014">INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</A></FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><B>You
should rely only on the information contained in this prospectus, including information incorporated by reference herein, and prospectus
supplement or any free writing prospectus prepared by or on behalf of us or to which we have referred you. Neither we nor the selling
shareholder have authorized anyone to provide you with different information. If anyone provides you with different or inconsistent information,
you should not rely on it. This prospectus does not constitute an offer to sell, or a solicitation of an offer to purchase, the securities
offered by this prospectus in any jurisdiction to or from any person to whom or from whom it is unlawful to make such offer or solicitation
of an offer in such jurisdiction. The information in this prospectus is accurate only as of the date of this prospectus, regardless of
the time of delivery of this prospectus or any sale of our securities.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For investors outside of the
United States: Neither we nor any of the selling shareholder have done anything that would permit this offering or possession or distribution
of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. You are required to
inform yourselves about and to observe any restrictions relating to this offering and the distribution of this prospectus. In this prospectus,
unless otherwise indicated, all references to the &ldquo;Company,&rdquo; &ldquo;we,&rdquo; &ldquo;our&rdquo; and &ldquo;Brenmiller&rdquo;
refer to Brenmiller Energy Ltd. and its subsidiaries, <FONT STYLE="background-color: white">Brenmiller Energy US Inc., a company incorporated
under the laws of Delaware, United States, Brenmiller Europe S.L., a company incorporated under the laws of the Kingdom of Spain, or Brenmiller
Europe</FONT>, and Bren Dom TES KFT, <FONT STYLE="background-color: white">a company incorporated under the laws of Hungary, </FONT>unless
the context otherwise requires.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On June 18, 2025, we announced
a 5-for-1 reverse share split of our issued and outstanding ordinary shares. All historical quantities of the ordinary shares and per
share data herein are presented on a post-split basis to give effect to our 5-for-1 reverse share split effected at the market open on
Nasdaq on June 20, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding-right: 5.4pt; padding-left: 5.4pt; border: Black 1.5pt solid; width: 98%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_001"></A>OUR COMPANY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Overview</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
are a technology company that develops, produces, markets and sells thermal energy storage, or TES, systems based on our proprietary and
patented bGen&trade; technology. Our technology enables the electrification and decarbonization of the industrials sector, resulting in
better integration with renewable energy sources and a reduction in carbon emissions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
believe that climate change is the greatest challenge of our times. A major contributor to climate change is carbon emissions being emitted
to the atmosphere. To combat this, countries and organizations have set and are continuing to set targets for themselves and various industries
to reduce their carbon emissions. In order to meet such carbon emission targets, we believe that we can contribute to expediting the transition
from fossil fuels to a widescale adoption of renewable energy, such as carbon capture, efficient energy storage and recovery, and benefitting
from the reuse of wasted heat. Our bGen&trade; TES system stores energy, and can convert electrical energy to heat, and/or recover wasted
heat from available energy resources to provide one consistent energy output. By doing so, the bGen&trade; TES system can produce clear
steam that precisely matches energy supplies with the demand and bridge the gap between renewable energy and conventional power sources.
Accordingly, we believe TES systems such as our bGen&trade; system have become essential to the industrial sectors and the renewable energy
market to ensure the reliability and stability of steam and other energy supplies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">We
have developed our bGen&trade; technology over the last thirteen years and have tested it across three generations of demonstration units
at various sites globally. Our bGen&trade; technology uses crushed rocks to store heat at temperatures of up to 1,400 degrees Fahrenheit
(760 degrees Celsius) and is comprised of several key elements inside one unit: thermal storage units called bCubes<SUP>tm</SUP>, heaters,
heat exchangers, electricity conversion to high temperature heat and a steam generator. The use of crushed rock as a means of heat storage
results in no hazardous challenges to the environment and enhances system durability so that even after tens of thousands of charge and
discharge cycles, the storage material does not degrade and so there is no need to replace the storage media. Additionally, the bGen&trade;
technology can be charged with multiple heat sources, such as, residual heat, and electrical heat from renewables, as well as from electrical
sources using electric heaters which are embedded within the TES system. The TES system dispatches thermal energy on demand in the form
of steam, which can be saturated for industrial use, or in the form of a superheated steam, which can be used to activate steam turbines.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In
2023, we also started the implementation of our new business models, the Energy as a Service, or EaaS, model, which includes also the
Heat as a Service, or HaaS, model, wherein we install a TES bGen<SUP>tm</SUP>&nbsp;system for the benefit of third party customers at
a customer&rsquo;s site and provide operation and maintenance services. We then sell energy (steam, hot air, etc.) to the customer at
agreed upon prices. The EaaS model is more suitable to industrial customers who are not energy experts and wish to outsource their energy
services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Recent Developments </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><I>July 2025 Private
Placement</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July 25, 2025, we entered
into a securities purchase agreement, or the July 2025 Securities Purchase Agreement, with Alpha Capital Anstalt, or Alpha. Pursuant to
the terms of the July 2025 Securities Purchase Agreement, we agreed to issue and sell to Alpha, subject to certain conditions, up to an
aggregate of $25 million in securities across multiple tranches, consisting of preferred shares, pre-funded warrants, and ordinary warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At the initial closing, which
took place on July 28, 2025, for a subscription amount of $1.2 million we issued (i) Pre-Funded Warrants to purchase 631,579 ordinary
shares at an exercise price of $0.00001 per share, or the Pre-Funded Warrants, and (ii) Ordinary Warrants to purchase 631,579 ordinary
shares at an exercise price of $2.09 per share. On August 11, 2025, we entered into an amendment to the July 2025 Securities Purchase
Agreement with Alpha, or the Amendment, and agreed, among other things, to amend the aggregate subscription amount of the Pre-Funded Warrants
and Ordinary Warrants in connection with the initial closing to $1,395,790. The Pre-Funded Warrants were exercisable upon issuance and
expired when exercised in full. On August 21, 2025 the Pre-Funded Warrants were exercised in full. The Ordinary Warrants are exercisable
upon issuance and expire five years from the initial exercise date. The exercise of the Pre-Funded Warrants and Ordinary Warrants are
subject to certain beneficial ownership limitations contained therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P></DIV>

<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="border: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; width: 98%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, on July 25, 2025,
we entered into two separate Registration Rights Agreements with Alpha pertaining to (i) the resale of the ordinary shares issuable upon
exercise of the warrants issued at the Pre-Funded Warrants Closing, or the Pre-Funded Warrants Registration Rights Agreement, and (ii)
the resale of the ordinary shares issuable upon conversion of the Preferred Shares and exercise of the Additional Ordinary Warrants to
be issued at the Equity Closing (as defined below), or the Equity Closing Registration Rights Agreement. We agreed to file these registration
statements with the U.S. Securities and Exchange Commission and maintain their effectiveness within specified timeframes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Also pursuant to the July
2025 Securities Purchase Agreement, following shareholder approval on September 25, 2025, we issued 3,800 Preferred Shares with a stated
value of $1,000 per share, in exchange for an additional $3.8 million investment, or the Equity Closing. Each Preferred Share is convertible
into ordinary shares at a fixed conversion price of $2.288 per share. At the Equity Closing, we also issued 1,660,839 accompanying ordinary
warrants, with an exercise price of $2.40 per share, equal to 100% of the shares underlying the Preferred Shares, which are exercisable
upon issuance and will expire five years from the initial exercise date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the Equity
Closing Registration Rights Agreement, we are obligated, among other things, to file this registration statement with the SEC, for purposes
of registering the sum of (i) 200% of the Ordinary Shares issued or issuable upon the conversion of the Preferred Shares issued pursuant
to the terms of the Securities Purchase Agreement, and (ii) the 200% warrant shares issued or issuable upon exercise of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the terms of the July
2025 Securities Purchase Agreement, subject to certain conditions and as long as any Preferred Shares or the underling warrants are outstanding,
Alpha also has the right to purchase additional preferred shares and warrants of up to an additional $20 million, or the Subsequent Financing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The July 2025 Securities Purchase
Agreement also provides for certain additional fundings by Alpha after the Equity Closing which can come in the form of warrant exercises,
Subsequent Financing or other financing arranged by Alpha, subject to certain conditions, up to $15 million, over a two year period beginning
after the Equity Closing. Assuming full exercise of all warrants, the overall financing from Alpha may reach approximately $50 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The July 2025 Securities Purchase
Agreement contains customary representations, warranties, covenants, and participation rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></DIV>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<DIV STYLE="border: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; width: 98%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_002"></A>ABOUT THIS OFFERING</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus relates to
the resale by the selling shareholder identified in this prospectus of up to 6,643,356 Ordinary Shares. All of the Ordinary Shares, when
sold, will be sold by the selling shareholder. The selling shareholder may sell the Ordinary Shares from time to time at prevailing market
prices. We will not receive any proceeds from the sale of the Ordinary Shares by the selling shareholder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 30%; padding-left: 9pt; text-indent: -9pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary
    Shares currently outstanding</FONT> </TD>
    <TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 69%; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,859,800
Ordinary Shares</FONT> </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 9pt; text-indent: -9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary Shares offered by the Selling Shareholder</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Up to 6,643,356 Ordinary Shares, consisting of (i) 1,660,839 Ordinary Shares issuable upon the conversion of 3,800 Preferred Shares, with a conversion price of $2.288 per share, (ii) up to 1,660,839 Additional Preferred Shares, reflecting 200% of the maximum number of shares issuable upon conversion of the Preferred Shares (without taking into account any limitations on the conversion of such Preferred Shares set forth therein), (iii) 1,660,839 Ordinary Shares issuable upon the exercise of ordinary warrants, with an exercise price of $2.40 per share, or the Ordinary Warrants and (iv) up to 1,660,839 Additional Ordinary Warrants reflecting 200% of the maximum number of warrant shares issuable upon exercise of the Warrants (without taking into account any limitations on the exercise of such Warrants set forth therein) (see &ldquo;<I>Our Company&mdash;Recent Developments&mdash;July 2025 Private Placement</I>&rdquo; for additional information).</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use of proceeds:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We will not receive any proceeds from the sale of the Ordinary Shares by the selling shareholder. All net proceeds from the sale of Ordinary Shares covered by this prospectus will go to the selling shareholder.&nbsp;However, we will receive cash proceeds equal to the conversion price of any Preferred Share that are converted to Ordinary Shares and the exercise price of any Warrants that are exercised. See &ldquo;Use of Proceeds.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk factors:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You should read the &ldquo;Risk Factors&rdquo; section starting on page 4 of this prospectus and &ldquo;Item 3. Key Information &ndash; D. Risk Factors&rdquo; in our most recent annual report on Form 20-F, incorporated by reference herein, and other information included or incorporated by reference in this prospectus for a discussion of factors to consider carefully before deciding to invest in our securities. </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasdaq Capital Market symbol:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;BNRG&rdquo;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.75pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> The number of Ordinary
Shares to be outstanding immediately after this offering as shown above assumes that all of the Ordinary Shares offered hereby are sold
and is based on 3,859,800 Ordinary Shares outstanding as of November 5, 2025. This number excludes: </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"> &nbsp; </TD>
    <TD STYLE="width: 0.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an aggregate of 103,805
    Ordinary Shares issuable upon the exercise of outstanding options to purchase Ordinary Shares, at exercise prices ranging between
    $0.05 to $1,235.5 per Ordinary Share, issued to directors, officers, service providers and employees;</FONT> </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD> &#9679; </TD>
    <TD STYLE="text-align: justify"> an aggregate of 3,489,795 Ordinary Shares issuable upon the exercise of outstanding warrants to
    purchase Ordinary Shares, at exercise prices ranging between $2.09 to $83.3 per Ordinary Share, issued to certain investors in connection
    with private placements and public offerings (including the Ordinary Shares issuable upon the exercise of Ordinary Warrants); </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD> &#9679; </TD>
    <TD STYLE="text-align: justify"> an aggregate of 1,660,839 Ordinary Shares issuable upon the conversion of 3,800 Preferred Shares,
    with a conversion price of $2.288 per share; and </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&#9679;</TD>
    <TD STYLE="text-align: justify"><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">the effect of the &ldquo;full-ratchet&rdquo;&nbsp;anti-dilution adjustment
of the conversion price of our outstanding Preferred Shares and warrants.</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></DIV>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_003"></A>RISK FACTORS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Investing in our securities
involves risks. Please carefully consider the risk factors described below and those contained in our periodic reports filed with the
Securities and Exchange Commission, or SEC, including those set forth under the caption &ldquo;Summary Risk Factors&rdquo; and &ldquo;Item
3. Key Information &ndash; D. Risk Factors&rdquo; in our 2024 Annual Report, which is incorporated by reference into this prospectus.
Before making an investment decision, you should carefully consider these risks as well as other information we include or incorporate
by reference in this prospectus. You should be able to bear a complete loss of your investment.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Risks Related to this Offering and Our Ordinary
Shares</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> <B><I>There can be no
assurance that we will be able to maintain the continued Nasdaq listing criteria.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August 12, 2024, we received
a written notice from the Nasdaq Stock Market indicating that we are not in compliance with the minimum bid price requirement for continued
listing set forth in Nasdaq Listing Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of $1.00 per share.
Under Nasdaq Listing Rule 5810(c)(3)(A), we were granted a grace period of 180 calendar days to regain compliance with the minimum bid
price requirement. On January 16, 2025, we announced that we received a written notice from Nasdaq that we have regained compliance with
the minimum bid price requirement for continued listing set forth in Nasdaq Listing Rule 5550(a)(2). The Nasdaq staff made this determination
of compliance after the closing bid price of our ordinary shares on Nasdaq was at $1.00 per share or greater for the 10 consecutive business
days prior to the date of the notice. Accordingly, we have regained compliance with Nasdaq Listing Rule 5550(a)(2), and Nasdaq considers
the prior bid price deficiency matter now closed. However, there can be no assurance that we will be able to maintain compliance with
the minimum bid price requirement or that we will otherwise be in compliance with other Nasdaq listing criteria.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Nasdaq Listing Rule 5550(b)(1)
requires listed companies to maintain stockholders&rsquo; equity of at least $2.5 million. As of June 30, 2025, our stockholders&rsquo;
equity was $1.193 million, which was below the minimum requirement. Although, following the Equity Closing on September 29, 2025 in
connection with the July 2025 Private Placement, we believe we currently demonstrate compliance with the stockholders&rsquo; equity requirement,
there can be no assurance that we will be able to maintain compliance with this or other applicable Nasdaq continued listing standards
in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If, for any reason, Nasdaq
delists our securities from trading on its exchange and we are not able to list our securities on another national securities exchange,
we expect our securities could be quoted on an over-the-counter market. If this were to occur, we could face significant material adverse
consequences, including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a limited availability of market quotations for our securities;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reduced liquidity for our securities;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a decrease in the number of institutional and general investors that will consider investing in our Ordinary Shares; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a determination that our ordinary shares are a &ldquo;penny stock&rdquo; which will require brokers trading in our Ordinary Shares to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for our securities.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Substantial future sales
or other issuances of our Ordinary Shares could depress the market for our Ordinary Shares.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Sales of a substantial number
of Ordinary Shares and any future sales of a substantial number of Ordinary Shares in the public market, including the issuance of shares
or any shares issuable upon the conversion of the Preferred Shares or the exercise of the Ordinary Warrants, or the perception by the
market that those sales could occur, could cause the market price of our Ordinary Shares to decline or could make it more difficult for
us to raise funds through the sale of equity and equity-related securities in the future at a time and price that our management deems
acceptable, or at all. In addition, as opportunities present themselves, we may enter into financing or similar arrangements in the future,
including the issuance of debt securities, preferred shares or Ordinary Shares, which could also depress the market for our Ordinary Shares.
We cannot predict the effect, if any, that market sales of those Ordinary Shares or the availability of those shares for sale will have
on the market price of our Ordinary Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the July
2025 Private Placement, under the terms of the July 2025 Securities Purchase Agreement, subject to certain conditions and as long as any
Preferred Shares or and accompanying ordinary warrants are outstanding, Alpha has the right to purchase additional preferred shares and
warrants from the Company, which will result in further dilution as well.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> <B><I>We have outstanding
warrants and preferred shares, some of which contain &ldquo;full-ratchet&rdquo; anti-dilution protection, which may cause significant
dilution to our shareholders.</I></B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have outstanding
warrants, which are exercisable into ordinary shares, and preferred shares, which are convertible into ordinary shares. The issuance
of the ordinary shares upon the exercise of the warrants or the conversion of such preferred shares would dilute the percentage
ownership interest of all shareholders, might dilute the book value per share of our ordinary shares and would increase the number
of our publicly traded shares, which could depress the market price of our ordinary shares. The warrants issued to Alpha on July 28,
2025 and on September 29, 2025 and the Preferred Shares issued to Alpha contain a &ldquo;full-ratchet&rdquo; anti-dilution provision
which, subject to limited exceptions, would reduce the exercise price of the warrants or the conversion price of the preferred
shares (and increase the number of shares issuable) in the event that we in the future issue ordinary shares, or securities
convertible into or exercisable to purchase ordinary shares, including any securities issued to alpha in connecting to subsequent
financing in connection to the July 2025 Securities Purchase Agreement, at a price per share lower than the applicable exercise
price or conversion price then in effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I></I></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>You may experience future
dilution as a result of future equity offerings and other issuances of our securities.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In order to raise additional
capital, we may in the future offer additional Ordinary Shares or other securities convertible into or exchangeable for our Ordinary Shares
prices that may not be the same as the price per share paid by the investors in this offering. We may not be able to sell shares or other
securities in any other offering at a price per share that is equal to or greater than the price per share paid by the investors in this
offering, and investors purchasing shares or other securities in the future could have rights superior to existing shareholders. The price
per share at which we sell additional Ordinary Shares or securities convertible into Ordinary Shares in future transactions may be higher
or lower than the price per share paid to the selling shareholders. Our shareholders will incur dilution upon exercise of any outstanding
share options, warrants or other convertible securities or upon the issuance of Ordinary Shares under our share incentive programs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any additional capital raised
through the sale of equity or equity-backed securities may dilute our shareholders&rsquo; ownership percentages and could also result
in a decrease in the market value of our equity securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The terms of any securities
issued by us in future capital transactions may be more favorable to new investors, and may include preferences, superior voting rights
and the issuance of warrants or other derivative securities, which may have a further dilutive effect on the holders of any of our securities
then outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, we may incur
substantial costs in pursuing future capital financing, including investment banking fees, legal fees, accounting fees, securities law
compliance fees, printing and distribution expenses and other costs. We may also be required to recognize non-cash expenses in connection
with certain securities we issue, such as convertible notes and warrants, which may adversely impact our financial condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"> <B><I>As
a result of the shutdown of the U.S. federal government, we have determined to rely on Section 8(a) of the Securities Act to cause the
registration statement of which this prospectus forms a part to become effective automatically. Our reliance on Section 8(a) could result
in a number of potential adverse consequences, including the need for us to file a post-effective amendment and distribute an updated
prospectus to investors, or a stop order issued preventing use of the registration statement, and a corresponding substantial share price
decline, litigation, reputational harm or other negative results.</I></B> </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"> <FONT STYLE="background-color: white">&nbsp;</FONT> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"> The
registration statement of which this prospectus forms a part is expected to become automatically effective by operation of Section 8(a)
of the Securities Act on the 20th calendar day after the most recent amendment of the registration statement filed with the SEC, in lieu
of the SEC declaring the registration statement effective following the completion of its review. Although our reliance on Section 8(a)
does not relieve us and other parties from the responsibility for the adequacy and accuracy of the disclosure set forth in the registration
statement and for ensuring that the registration statement complies with applicable requirements, use of Section 8(a) poses a risk that,
after the date of this prospectus, we may be required to file a post-effective amendment to the registration statement and distribute
an updated prospectus to investors, or otherwise abandon this offering, if changes to the information in this prospectus are required,
or if a stop order under Section 8(d) of the Securities Act prevents continued use of the registration statement. These or similar events
could cause the trading price of our Ordinary Shares to decline substantially, result in securities class action or other litigation,
and subject us to significant monetary damages, reputational harm and other negative results. </P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="background-color: white">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="background-color: white">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><FONT STYLE="background-color: white"><B>Risks
Related to our Incorporation and Our Operations in Israel</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="background-color: white"><B><I>Potential
political, economic and military instability in Israel, where our headquarters, members of our management team, our production facilities,
and employees are located, may adversely affect our results of operations.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="background-color: white">Our
executive offices and production plant, wherein most of our employees are employed, are located in Rosh Haayin and Dimona, Israel. In
addition, the majority of our key employees, officers, and directors are Israeli citizens. Accordingly, political, economic, and military
conditions in Israel may directly affect our business. Since the establishment of the State of Israel in 1948, a number of armed conflicts
have taken place between Israel and groups in its neighboring countries, Hamas (an Islamist militia and political group that has controlled
the Gaza Strip) and Hezbollah (an Islamist militia and political group based in Lebanon). While Israel has entered into peace agreements
with Egypt, Jordan, the United Arab Emirates, Bahrain, Morocco and Sudan, it has no peace arrangements with any other neighboring or other
Arab countries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="background-color: white">In
April&nbsp;2024 and October&nbsp;2024,&nbsp;Iran&nbsp;launched direct attacks on Israel involving hundreds of drones and missiles and
has threatened to continue to attack Israel. On June&nbsp;13, 2025, in light of continued nuclear threats and intelligence assessments
indicating imminent attacks, Israel launched a preemptive strike directly targeting military and nuclear infrastructure inside Iran aimed
to disrupt Iran&rsquo;s capacity to coordinate or launch further hostilities against Israel, as well as disrupt its nuclear program. On
June&nbsp;21, 2025, the United&nbsp;States military conducted targeted air strikes against three nuclear sites within Iran and on June&nbsp;23,
2025 Iran retaliated against U.S.&nbsp;interests in the region.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="background-color: white">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="background-color: white">On
June&nbsp;24, 2025, a ceasefire was implemented between Iran and Israel and, as of July&nbsp;1, 2025, still remains in place. Nonetheless,
hostilities between Iran and Israel and the United&nbsp;States may resume in the near future, which could create significant volatility
in the global economy as well as disruptions to global supply chains. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"> Further,
many Israeli citizens are obligated to perform several days, and in some cases, more, of annual military reserve duty each year until
they reach the age of 40 (or older for certain reservists). In response to increases in terrorist and military activity hostile to Israel,
there have been periods of significant call-ups of military reservists to active duty. For example, on October 7, 2023, Hamas terrorists
invaded southern Israel and launched thousands of rockets in a widespread terrorist attack on Israel. On the same day, the Israeli government
declared that the country was at war and the Israeli military began to call-up reservists for active duty, including a few of our employees.
As of November 5, 2025, one of our employees, who is not a member of our management, is deployed for reserve military service. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"> As
of October 9, 2025, Israel and Hamas have entered into a ceasefire agreement intended to permanently end the war. However, there are
no assurances that such an agreement will hold. The security situation in the region remains fluid and any renewed military actions,
restrictions, or government-imposed measures could adversely affect our operations and financial condition. While none of our facilities
or infrastructure have been damaged since the war with Hamas broke out on October 7, 2023, the import and export of goods may experience
disruptions in and out of Israel as a result of military conflict. A prolonged war could result in further military reserve duty call-ups
in the future as well as irregularities to our supply chain and the movement of components and raw material into Israel and our finished
products exported from Israel. Such disruption could materially adversely affect our business, prospects, financial condition, and results
of operations. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="background-color: white">In
addition, several countries, principally in the Middle East, restrict doing business with Israel, and additional countries may impose
restrictions on doing business with Israel and Israeli companies whether as a result of hostilities in the region or otherwise. The restrictive
laws, policies, or practices directed towards Israel or Israeli businesses could, individually or in the aggregate, have a material adverse
effect on our business in the future, for example by way of sales opportunities that we could not pursue or from which we will be precluded.
In addition, should the movement for boycotting, divesting, and sanctioning Israel and Israeli institutions (including universities) and
products become increasingly influential in the United States and Europe, this may also adversely affect our business and financial condition.
Further deterioration of Israel&rsquo;s relations with the Palestinian Authority or countries in the Middle East could expand the disruption
of international trading activities in Israel, may materially and negatively affect our business conditions, could harm our results of
operations, and adversely affect the market price of our Ordinary Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="background-color: white">Any
hostilities involving Israel, terrorist activities, political instability or violence in the region, or the interruption or curtailment
of trade or transport between Israel and its trading partners could adversely affect our operations and results of operations and the
market price of our Ordinary Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="background-color: white">Our
commercial insurance does not cover losses that may occur as a result of an event associated with the security situation in the Middle
East. Although the Israeli government is currently committed to covering the reinstatement value of direct damages that are caused by
terrorist attacks or acts of war, we cannot assure you that this government coverage will be maintained or, if maintained, will be sufficient
to compensate us fully for damages incurred. Any losses or damages incurred by us could have a material adverse effect on our business,
financial condition, and results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="background-color: white">Furthermore,
the Israeli government is currently pursuing extensive changes to Israel&rsquo;s judicial system. In response, individuals, organizations
and institutions, both within and outside of Israel, have voiced concerns that the proposed changes may negatively impact the business
environment in Israel including due to reluctance of foreign investors to invest or conduct business in Israel, as well as to increased
currency fluctuations, downgrades in credit rating, increased interest rates, increased volatility in securities markets and other changes
in macroeconomic conditions. Such proposed changes may also adversely affect the labor market in Israel or lead to political instability
or civil unrest. To the extent that any of these negative developments do occur, they may have an adverse effect on our business, our
results of operations, financial condition and our ability to raise additional funds.<B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="background-color: white"><B>General
Risk Factors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="background-color: white"><B><I>Our
amended and restated articles of association provide that, unless we consent in writing to an alternative forum, the federal district
courts of the United States of America shall be the sole and exclusive forum for resolution of any complaint asserting a cause of action
arising under the Securities Act, which could limit our shareholders&rsquo; ability to choose the judicial forum for disputes with us,
our directors, shareholders, or other employees.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="background-color: white">Our
amended and restated articles of association provide that, unless we consent in writing to the selection of an alternative forum, the
federal district courts of the United States of America shall be the exclusive forum for the resolution of any complaint asserting a cause
of action arising under the Securities Act. Section 22 of the Securities Act creates concurrent jurisdiction for U.S. federal and state
courts over all such Securities Act actions. Accordingly, both U.S. state and federal courts have jurisdiction to entertain such claims.
To prevent having to litigate claims in multiple jurisdictions and the threat of inconsistent or contrary rulings by different courts,
among other considerations, our amended and restated articles of association provide that, unless we consent in writing to the selection
of an alternative forum, the federal district courts of the United States shall be the exclusive forum for the resolution of any complaint
asserting a cause of action arising under the Securities Act. This exclusive forum provision will not apply to suits brought to enforce
any liability or duty created by the Exchange Act, and our shareholders cannot and will not be deemed to have waived our compliance with
the U.S. federal securities laws and the rules and regulations promulgated under the Securities Act or the Exchange Act as a result of
our exclusive forum provision.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="background-color: white">Any
person or entity purchasing or otherwise acquiring any interest in any of our securities shall be deemed to have notice of and consented
to the foregoing provision of our amended and restated articles of association. However, the enforceability of similar forum provisions
(including exclusive federal forum provisions for actions, suits, or proceedings asserting a cause of action arising under the Securities
Act) in other companies&rsquo; organizational documents has been challenged in legal proceedings, and there is uncertainty as to whether
courts would enforce the exclusive forum provision in our amended and restated articles of association. If a court were to find the exclusive
forum provision contained in our amended and restated articles of association to be inapplicable or unenforceable in an action, we may
incur additional costs associated with resolving such action in other jurisdictions, which could materially adversely affect our business,
financial condition, and results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="background-color: white">Although
we believe the exclusive forum provision benefit us by providing increased consistency in the application of U.S. federal securities laws
the Israeli Companies Law, or New York law, as applicable, in the types of lawsuits to which they apply, such exclusive forum provision
may limit a shareholder&rsquo;s ability to bring a claim in the judicial forum that they find favorable and may increase certain litigation
costs for disputes with us or any of our directors, shareholders, officers, or other employees, which may discourage lawsuits with respect
to such claims against us and our current and former directors, shareholders, officers, or other employees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_004"></A>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Some of the statements made
under &ldquo;Risk Factors,&rdquo; &ldquo;Use of Proceeds,&rdquo; and elsewhere in this prospectus, including in our 2024 Annual Report,
incorporated by reference herein, and other information included or incorporated by reference in this prospectus, constitute forward-looking
statements. Forward-looking statements are often characterized by the use of forward-looking terminology such as &ldquo;may,&rdquo; &ldquo;will,&rdquo;
&ldquo;expect,&rdquo; &ldquo;anticipate,&rdquo;, &ldquo;plan,&rdquo; &ldquo;estimate,&rdquo; &ldquo;continue,&rdquo; &ldquo;believe,&rdquo;
&ldquo;should,&rdquo; &ldquo;intend,&rdquo; &ldquo;project,&rdquo; &ldquo;predict,&rdquo; &ldquo;potential&rdquo; or other similar words,
but are not the only way these statements are identified.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">These forward-looking statements
may include, but are not limited to, statements relating to our objectives, plans and strategies, statements that contain projections
of results of operations or of financial condition, expected capital needs and expenses, statements relating to the research, development,
completion and use of our products, and all statements (other than statements of historical facts) that address activities, events or
developments that we intend, expect, project, believe or anticipate will or may occur in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Forward-looking statements
are not guarantees of future performance and are subject to risks and uncertainties. We have based these forward-looking statements on
assumptions and assessments made by our management in light of their experience and their perception of historical trends, current conditions,
expected future developments and other factors they believe to be appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Important factors that could
cause actual results, developments and business decisions to differ materially from those anticipated in these forward-looking statements
include, among other things:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our planned level of revenues and capital expenditures;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to market and sell our products;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our plans to continue to invest in research and development to develop technology for both existing and new products;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to maintain our relationships with suppliers, manufacturers, and other partners;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to maintain or protect the validity of our European, U.S., and other patents and other intellectual property;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to retain key executive members;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to internally develop and protect new inventions and intellectual property;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to expose and educate the industry about the use of our products;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our expectations regarding our tax classifications;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our ability to maintain compliance with Nasdaq&rsquo;s continued listing requirements;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">interpretations of current laws and the passages of future laws; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">general market, political, and economic conditions in the countries in which we operate including those related to recent unrest and actual or potential armed conflict in Israel and other parts of the Middle East, such as the multi-front war Israel is facing.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">These statements are only
current predictions and are subject to known and unknown risks, uncertainties, and other factors that may cause our or our industry&rsquo;s
actual results, levels of activity, performance or achievements to be materially different from those anticipated by the forward-looking
statements. We discuss many of these risks in this prospectus in greater detail under the heading &ldquo;Risk Factors&rdquo; and elsewhere
in this prospectus. You should not rely upon forward-looking statements as predictions of future events.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although we believe that the
expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance,
or achievements. Except as required by law, we are under no duty to update or revise any of the forward-looking statements, whether as
a result of new information, future events or otherwise, after the date of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_005"></A>USE OF PROCEEDS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will not receive any proceeds
from the sale of the Ordinary Shares by the selling shareholder. All net proceeds from the sale of the Ordinary Shares covered by this
prospectus will go to the selling shareholder. However, we will receive cash proceeds equal to conversion price of any Preferred Shares
that are converted to Ordinary Shares and the exercise price of the Warrants that are exercised.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We intend to use the proceeds
from the conversion of any Preferred Shares and exercise of the Warrants for general corporate purposes, working capital, and execution
of our commercial TES projects across Europe, the U.S., and the Middle East.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_006"></A>capitalization</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth
our cash and cash equivalents and our capitalization as of June 30, 2025:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on an actual basis; </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on a <I>pro forma</I> basis which gives effect to: &nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">the issuance and sale of 476,323 Ordinary Shares from July 1, 2025 to the date of this prospectus pursuant
to an &ldquo;at the market offering&rdquo; program and the receipt, of net proceeds of $1,124 thousand from such sales;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">the issuance of an aggregate of 24,850 Ordinary Shares with respect to 24,850 restricted share units we
have granted to service providers from July 1, 2025 to the date of this prospectus; and</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">the issuance of 631,579 ordinary shares with respect to exercise of 631,579 Pre-Funded Warrants and sale
of 3,800 Preferred Shares and 2,292,418 warrants pursuant to the July 2025 Securities Purchase Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on a <I>pro forma</I> as adjusted basis to give effect to (i) to give effect to the full conversion of Preferred Shares at the conversion price of $2.288, and (ii) the full exercise of the Ordinary Warrants at an exercise price of $2.40 per share.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table should be read in conjunction with &ldquo;Use of
Proceeds,&rdquo; our Condensed Consolidated Financial Statements as of and for the Six-Month Period Ended June 30, 2025 and &ldquo;Management&rsquo;s
Discussion and Analysis of Financial Condition and Results of Operations&rdquo; attached as exhibits 99.2 and 99.3, respectively, to our
Report of Foreign Private Issuer on Form 6-K, filed with the SEC on September 30, 2025 that are incorporated by reference into this form,
and the other financial information included or incorporated by reference herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As of June 30, 2025</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; font-style: italic; border-bottom: Black 1.5pt solid">U.S. dollars in thousands</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Actual</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; font-style: italic; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; font-style: italic; text-align: center; border-bottom: Black 1.5pt solid">Pro forma</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-style: italic">&nbsp;</TD><TD STYLE="font-weight: bold; font-style: italic; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; font-style: italic; text-align: center; border-bottom: Black 1.5pt solid">Pro forma<BR> as adjusted</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-style: italic">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; width: 64%; text-align: left; padding-bottom: 4pt">Cash and cash equivalents</TD><TD STYLE="width: 1%; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="width: 9%; border-bottom: Black 4pt double; text-align: right">2,127</TD><TD STYLE="width: 1%; padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="width: 9%; border-bottom: Black 4pt double; text-align: right">8,365</TD><TD STYLE="width: 1%; padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="width: 9%; border-bottom: Black 4pt double; text-align: right">12,351</TD><TD STYLE="width: 1%; padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">Debt:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">European Investment Bank (&ldquo;EIB&rdquo;) loan</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,885</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,885</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,885</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Warrants&rsquo; liability</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">4</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">4</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">4</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Total debt</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">4,889</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">4,889</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">4,889</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Shareholders&rsquo; equity:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Ordinary Shares, no par value- authorized 150,000,000; Issued and outstanding 2,727,048 as of June 30, 2025; 150,000,000 Ordinary Shares authorized 3,859,800 shares issued outstanding, pro forma and 150,000,000 Ordinary Shares authorized, 7,181,478 shares issued outstanding, pro forma as adjusted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">124</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">124</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">124</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Additional paid in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">112,776</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">119,014</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">123,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Foreign currency cumulative translation reserve</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,053</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,053</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,053</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Accumulated deficit</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(109,654</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(109,654</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(109,654</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Total equity</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,193</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">7,431</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">11,417</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 4pt">Total capitalization</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">6,082</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">12,320</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">16,306</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_007"></A>SELLING SHAREHOLDER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July 25, 2025, we entered
into a securities purchase agreement with Alpha in connection with the July 2025 Private Placement. The up to 6,643,356 Ordinary Shares
being offered by the selling shareholder, is the aggregate of (i) 1,660,839 Ordinary Shares issuable upon the conversion of 3,800 preferred
shares, with a conversion price of $2.288 per share, (ii) up to 1,660,839 Ordinary Shares issuable upon the conversion of 3,800 preferred
shares, reflecting 200% of the maximum number of shares issuable upon conversion of the Preferred Shares (without taking into account
any limitations on the conversion of such Preferred Shares set forth therein), (iii) up to 1,660,839 Ordinary Shares issuable upon the
exercise of ordinary warrants, with an exercise price of $2.40 per share, (iv) up to 1,660,839 Ordinary Shares issuable upon exercise
of ordinary warrants,&nbsp;reflecting 200% of the maximum number of warrant shares issuable upon exercise of the Warrants (without taking
into account any limitations on the exercise of such Warrants set forth therein) (see &ldquo;<I>Our Company&mdash;Recent Developments&mdash;July
2025 Private Placement</I>&rdquo; for additional information). We are registering the Ordinary Shares in order to permit the selling shareholder
to offer the Ordinary Shares for resale from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Other than the
relationships described herein, and in previous public disclosures by Alpha, to our knowledge, the selling shareholder has not had
any material relationship with us within the past three years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any selling shareholder that
is an affiliate of broker-dealers and any participating broker-dealers would be deemed to be an &ldquo;underwriter&rdquo; within the meaning
of the Securities Act, and any commissions or discounts given to any such selling shareholder or broker-dealer may be regarded as underwriting
commissions or discounts under the Securities Act. To our knowledge, the selling shareholder listed below is not a broker-dealer or affiliate
of a broker-dealer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The table below lists the
selling shareholder and other information regarding the beneficial ownership of the Ordinary Shares by the selling shareholder. The second
column lists the number of Ordinary Shares beneficially owned by the selling shareholder, based on its ownership of the Ordinary Shares,
as of the date set forth in the relevant footnote next to the selling shareholder&rsquo;s name. The fourth column assumes the sale of
all of the Ordinary Shares offered by the selling shareholder pursuant to this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In accordance with the terms
of the July 2025 Private Placement, this prospectus generally covers the resale of &nbsp;(i) 200% of the Ordinary Shares issued or issuable
upon the conversion of the Preferred Shares issued pursuant to the terms of the Securities Purchase Agreement, (ii) 200% of the Ordinary
Shares issued or issuable upon exercise of the Ordinary Warrants. Because the number of Ordinary Shares may be adjusted for reverse and
forward share splits, share dividends, share combinations and other similar transactions, the number of Ordinary Shares that will actually
be issued may be more or less than the number of Ordinary Shares being offered by this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The term &ldquo;selling shareholder&rdquo;
also includes any transferees, pledgees, donees, or other successors in interest to the selling shareholder named in the table below.
Unless otherwise indicated, to our knowledge, the selling shareholder named in the table below has sole voting and investment power (subject
to applicable community property laws) with respect to the Ordinary Shares set forth opposite its name. We will file a supplement to this
prospectus (or a post-effective amendment to the registration statement of which this prospectus forms a part, if necessary) to name successors
to the selling shareholder who is able to use this prospectus to resell the securities registered hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The columns titled &ldquo;Maximum
Number of Shares to be Sold Pursuant to this Prospectus&rdquo; and &ldquo;Shares Owned Immediately After Sale of Maximum Number of Shares
in this Offering&rdquo; assume the conversion of the Preferred Shares at a conversion price of $2.288, and the Ordinary Warrants at an
exercise price of $2.40.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> Under the terms of the
Preferred Shares and the Warrants, a selling shareholder may not convert the Preferred Shares or exercise the Warrants to the extent
such selling shareholder or any of its affiliates would beneficially own a number of shares of our Ordinary Shares which would exceed
9.99% of our outstanding shares. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The selling shareholder may sell all, some or
none of its shares in this offering. See &ldquo;Plan of Distribution.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shares <BR> Beneficially Owned<BR> Prior to Offering<SUP>(1)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Maximum<BR> Number of<BR> Shares to<BR> be Sold<BR> Pursuant <BR> to this<BR> Prospectus</TD><TD STYLE="padding-bottom: 6pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Shares Owned<BR> Immediately After Sale of<BR> Maximum Number of<BR> Shares in this Offering</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid">Name of Selling Shareholder</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number</TD><TD STYLE="padding-bottom: 6pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Percentage<SUP>(2)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number</TD><TD STYLE="padding-bottom: 6pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number</TD><TD STYLE="padding-bottom: 6pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Percentage<SUP>&nbsp;(3)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; text-align: left">Alpha Capital Anstalt</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">385,594</TD><TD STYLE="padding-bottom: 6pt; width: 1%; text-align: left"><SUP>(3)</SUP></TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">9.99</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">3,321,678</TD><TD STYLE="padding-bottom: 6pt; width: 1%; text-align: left"><SUP>(5)</SUP></TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">717,430</TD><TD STYLE="padding-bottom: 6pt; width: 1%; text-align: left"><SUP>(4)</SUP></TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">9.99</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT> </TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial ownership
    is determined in accordance with SEC rules and generally includes voting or investment power with respect to securities. Ordinary
    Shares subject to options or warrants currently exercisable, or exercisable within 60 days of November 5, 2025, are counted as
    outstanding for computing the percentage of the selling shareholder holding such options or warrants but are not counted as outstanding
    for computing the percentage of any other selling shareholder.</FONT> </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT> </TD>
    <TD STYLE="text-align: justify"><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"> The applicable percentage of
                                    beneficial ownership is based on 3,859,800 Ordinary Shares issued and outstanding as of November
                                    5, 2025, excluding the Preferred Shares and the Ordinary Warrants. </P> </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD> (3) &nbsp; </TD>
    <TD STYLE="text-align: justify"> Based on: (i) 346,363 <FONT STYLE="background-color: white">Ordinary Shares issued and outstanding;
    (ii) </FONT>2,298,868 <FONT STYLE="background-color: white">Ordinary Shares issuable upon the exercise of warrants exercisable within
    60 days of </FONT>November 5<FONT STYLE="background-color: white">, 2025,</FONT> which contain a beneficial ownership limitation
    of 9.99%; and (iii) 1,660,839 Ordinary Shares issuable upon the conversion of Preferred Shares convertible within 60 days of November
    5, 2025, which contain a beneficial ownership limitation of 9.99%. <FONT STYLE="background-color: white">The address for Alpha
    Capital Anstalt is Lettstrasse 32, Vaduz 9490, Liechtenstein. Nicola Feuerstein, a Director of Alpha Capital Anstalt, holds voting
    and dispositive power over the securities held by Alpha Capital Anstalt. Based on information contained on a Schedule 13G/A filed
    by Alpha Capital Anstalt with the SEC </FONT>on November 5, 2025. </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD> (4) </TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> Based on: (i) 346,363 <FONT STYLE="background-color: white">Ordinary
        Shares issued and outstanding and (ii) 638,029 Ordinary Shares issuable upon the exercise of warrants exercisable within 60 days
        of</FONT> November 5<FONT STYLE="background-color: white">, 2025,</FONT> which contain a beneficial ownership limitation of
        9.99%. <FONT STYLE="background-color: white">The address for Alpha Capital Anstalt is Lettstrasse 32, Vaduz 9490, Liechtenstein.
        Nicola Feuerstein, a Director of Alpha Capital Anstalt, holds voting and dispositive power over the securities held by Alpha
        Capital Anstalt. Based on information contained on a Schedule 13G/A filed by Alpha Capital Anstalt with the SEC </FONT>on November
        5, 2025. </P>
</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>(5)</TD>
    <TD STYLE="text-align: justify">Assumes the conversion of the Preferred Shares at a conversion price of $2.288, and the Ordinary Warrants at an exercise price of $2.40.</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_008"></A>PLAN OF DISTRIBUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The selling shareholder of
the securities and any of its pledgees, assignees and successors-in-interest may, from time to time, sell any or all of the securities
covered hereby on the principal trading market or any other share exchange, market or trading facility on which the securities are traded
or in private transactions. These sales may be at fixed or negotiated prices. The selling shareholder may use any one or more of the following
methods when selling securities:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">block trades in which the broker-dealer will attempt to sell the securities as agent but may position
and resell a portion of the block as principal to facilitate the transaction;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">purchases by a broker-dealer as principal and resale by the broker-dealer for its account;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">an exchange distribution in accordance with the rules of the applicable exchange;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">privately negotiated transactions;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">settlement of short sales;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">in transactions through broker-dealers that agree with the selling shareholder to sell a specified number
of such securities at a stipulated price per security;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">through the writing or settlement of options or other hedging transactions, whether through an options
exchange or otherwise;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">a combination of any such methods of sale; or</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD STYLE="text-align: justify">any other method permitted pursuant to applicable law.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The selling shareholder may
also sell securities under Rule 144 or any other exemption from registration under the Securities Act, if available, rather than under
this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Broker-dealers engaged by
the selling shareholder may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions or discounts
from the selling shareholder (or, if any broker-dealer acts as agent for the purchaser of securities, from the purchaser) in amounts to
be negotiated, but, except as set forth in a supplement to this prospectus, in the case of an agency transaction not in excess of a customary
brokerage commission in compliance with Rule 2440 of the Financial Industry Regulatory Authority, or FINRA, and in the case of a principal
transaction a markup or markdown in compliance with FINRA IM-2440.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the sale
of the securities or interests therein, the selling shareholder may enter into hedging transactions with broker-dealers or other financial
institutions, which may in turn engage in short sales of the securities in the course of hedging the positions they assume. The selling
shareholder may also sell securities short and deliver these securities to close out his short positions, or loan or pledge the securities
to broker-dealers that in turn may sell these securities. The selling shareholder may also enter into option or other transactions with
broker-dealers or other financial institutions or create one or more derivative securities which require the delivery to such broker-dealer
or other financial institution of securities offered by this prospectus, which securities such broker-dealer or other financial institution
may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The selling shareholder and
any broker-dealers or agents that are involved in selling the securities may be deemed to be &ldquo;underwriters&rdquo; within the meaning
of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers or agents and any
profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts under the Securities
Act. The selling shareholder has informed the Company that it does not have any written or oral agreement or understanding, directly or
indirectly, with any person to distribute the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are required to pay certain
fees and expenses incurred by us incident to the registration of the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The resale securities will
be sold only through registered or licensed brokers or dealers if required under applicable state securities laws. In addition, in certain
states, the resale securities covered hereby may not be sold unless they have been registered or qualified for sale in the applicable
state or an exemption from the registration or qualification requirement is available and is complied with.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under applicable rules and
regulations under the Securities Exchange Act of 1934, as amended, or the Exchange Act, any person engaged in the distribution of the
resale securities may not simultaneously engage in market making activities with respect to the Ordinary Shares for the applicable restricted
period, as defined in Regulation M, prior to the commencement of the distribution. In addition, the selling shareholder will be subject
to applicable provisions of the Exchange Act and the rules and regulations thereunder, including Regulation M, which may limit the timing
of purchases and sales of the Ordinary Shares by the selling shareholder or any other person. We will make copies of this prospectus available
to the selling shareholder and have informed them of the need to deliver a copy of this prospectus to each purchaser at or prior to the
time of the sale (including by compliance with Rule 172 under the Securities Act).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Offer Restrictions Outside the United States</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Other than in the United States,
no action has been taken by us or the selling shareholder that would permit a public offering of the securities offered by this prospectus
in any jurisdiction where action for that purpose is required. The securities offered by this prospectus may not be offered or sold, directly
or indirectly, nor may this prospectus or any other offering material or advertisements in connection with the offer and sale of any such
securities be distributed or published in any jurisdiction, except under circumstances that will result in compliance with the applicable
rules and regulations of that jurisdiction. Persons into whose possession this prospectus comes are advised to inform themselves about
and to observe any restrictions relating to the offering and the distribution of this prospectus. This prospectus does not constitute
an offer to sell or a solicitation of an offer to buy any securities offered by this prospectus in any jurisdiction in which such an offer
or a solicitation is unlawful.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_009"></A>LEGAL MATTERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain legal matters concerning
this offering were passed upon for us by Sullivan &amp; Worcester LLP, New York, New York. Certain legal matters with respect to the legality
of the issuance of the securities offered by this prospectus were passed upon for us by Sullivan &amp; Worcester Tel Aviv (Har-Even &amp;
Co.), Tel Aviv, Israel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_010"></A>EXPERTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The financial statements incorporated
in this Prospectus by reference to the Annual Report on Form 20-F for the year ended December 31, 2024 have been so incorporated in reliance
on the report (which contains an explanatory paragraph relating to the Company&rsquo;s ability to continue as a going concern as described
in Note 1C to the financial statements) of Kesselman &amp; Kesselman, Certified Public Accountants (Isr.), a member firm of PricewaterhouseCoopers
International Limited, an independent registered public accounting firm, given on the authority of said firm as experts in auditing and
accounting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_011"></A>EXPENSES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following are the estimated
expenses of this offering payable by us related to the filing of the registration statement of which this prospectus forms a part. With
the exception of the SEC registration fee, all amounts are estimates and may change:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; text-align: left">SEC registration fee</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">1,431.22</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Printer fees and expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">500</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Legal fees and expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">50,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Accounting fees and expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt">Miscellaneous</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">1,068.78</P></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 4pt">Total</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">55,000</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_012"></A>ENFORCEABILITY OF CIVIL LIABILITIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are incorporated
under the laws of the State of Israel. Service of process upon us and upon our directors and officers and the Israeli experts named
in the registration statement of which this prospectus forms a part, a substantial majority of whom reside outside of the United
States, may be difficult to obtain within the United States. Furthermore, because substantially all of our assets and a substantial
number of our directors and officers are located outside of the United States, any judgment obtained in the United States against us
or any of our directors and officers may not be collectible within the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have been informed by our
legal counsel in Israel, Sullivan &amp; Worcester Tel-Aviv (Har-Even &amp; Co.), Tel Aviv, Israel, that it may be difficult to assert
U.S. securities law claims in original actions instituted in Israel. Israeli courts may refuse to hear a claim based on a violation of
U.S. securities laws because Israel is not the most appropriate forum to bring such a claim. In addition, even if an Israeli court agrees
to hear a claim if U.S. law is found to be applicable, the content of applicable U.S. law must be proved as a fact which can be a time-consuming
and costly process. Certain matters of the procedure will also be governed by Israeli law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to specified time
limitations and legal procedures, Israeli courts may enforce a U.S. judgment in a civil matter which, subject to certain exceptions, is
non-appealable, including judgments based upon the civil liability provisions of the Securities Act and the Exchange Act and including
a monetary or compensatory judgment in a non-civil matter, provided that among other things:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>the judgment is obtained after due process before a court of competent jurisdiction, according to the laws of the state in which the
judgment is given;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>the judgment is final and is not subject to any right of appeal;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>the prevailing law of the foreign state in which the judgment was rendered allows for the enforcement of judgments of Israeli courts.
However, the court may enforce a foreign judgment, even without reciprocity, based on the request of the Attorney General, under certain
circumstances;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>the liabilities under the judgment are enforceable according to the laws of the State of Israel and the judgment and the enforcement
of the civil liabilities set forth in the judgment is not contrary to the law or public policy in Israel;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>the judgment was not obtained by fraud, there was a reasonable opportunity for the defendant to present their case, the judgment was
given by an authorized court to issue it under the applicable international private law rules in Israel, and the judgement does not conflict
with any other valid judgments in the same matter between the same parties;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>an action between the same parties in the same matter is not pending in any Israeli court at the time the lawsuit is instituted in
the foreign court;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>the judgment is enforceable according to the of the foreign state in which it was granted; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>enforcement may be denied if it could harm the sovereignty or security of the State of Israel.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If a foreign judgment is declared
enforceable by an Israeli court, it generally will be payable in Israeli currency. The conversion to Israeli currency will be based on
the latest official exchange rate published by the Bank of Israel before the payment date. However, the obligated party will fulfill its
duty by the judgment even if they choose to make the payment in the same foreign currency, subject to the laws governing the foreign currency
applicable at that time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pending collection, the amount
of the judgment of an Israeli court stated in Israeli currency ordinarily will be linked to the Israeli consumer price index plus interest
at the annual statutory rate set by Israeli regulations prevailing at the time. Judgment creditors must bear the risk of unfavorable exchange
rates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_013"></A>WHERE YOU CAN FIND ADDITIONAL INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are an Israeli company
and are a &ldquo;foreign private issuer&rdquo; as defined in Rule 3b-4 under the Exchange Act. As a foreign private issuer, we are exempt
from the rules under the Exchange Act related to the furnishing and content of proxy statements, and our officers, directors and principal
shareholders are exempt from the reporting and short-swing profit recovery provisions contained in Section 16 of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, we are not required
under the Exchange Act to file annual, quarterly and current reports and financial statements with the SEC as frequently or as promptly
as U.S. companies whose securities are registered under the Exchange Act. However, we file with the SEC, within 120 days after the end
of each fiscal year, or such applicable time as required by the SEC, an annual report on Form 20-F containing financial statements audited
by an independent registered public accounting firm, and submit to the SEC, on a Form 6-K, unaudited interim financial information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We maintain a corporate website
at http://www.bren-energy.com. We will post on our website any materials required to be so posted on such website under applicable corporate
or securities laws and regulations, including any notices of general meetings of our shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The SEC also maintains a web
site that contains information we file electronically with the SEC, which you can access over the Internet at http://www.sec.gov. Information
contained on, or that can be accessed through, our website and other websites listed in this prospectus do not constitute a part of this
prospectus. We have included these website addresses in this prospectus solely as inactive textual references.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This prospectus is part of
a registration statement on Form F-3 filed by us with the SEC under the Securities Act. As permitted by the rules and regulations of the
SEC, this prospectus does not contain all the information set forth in the registration statement and the exhibits thereto filed with
the SEC. For further information with respect to us and the securities offered hereby, you should refer to the complete registration statement
on Form F-3, which may be obtained from the locations described above. Statements contained in this prospectus or in any prospectus supplement
about the contents of any contract or other document are not necessarily complete. If we have filed any contract or other document as
an exhibit to the registration statement or any other document incorporated by reference in the registration statement, you should read
the exhibit for a more complete understanding of the document or matter involved. Each statement regarding a contract or other document
is qualified in its entirety by reference to the actual document.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B></B></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_014"></A>INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The SEC allows us to &ldquo;incorporate
by reference&rdquo; the information we file with it, which means that we can disclose important information to you by referring you to
those documents. The information incorporated by reference is considered to be part of this prospectus and information we file later with
the SEC will automatically update and supersede this information. The documents we are incorporating by reference as of their respective
dates of filing are:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Annual Report on </FONT><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1901215/000121390025020178/ea0231962-20f_brenmiller.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form 20-F</FONT></A> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">for the year ended December 31, 2024, filed on March 4, 2025;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px; font-size: 10pt"> &nbsp; </TD>
    <TD STYLE="width: 24px; font-size: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT> </TD>
    <TD STYLE="text-align: justify; font-size: 10pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    Reports of Foreign Private Issuer on Form 6-K, submitted on </FONT><A HREF="https://www.sec.gov/Archives/edgar/data/1901215/000121390025024118/ea0234404-6k_brenmiller.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    14, 2025</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">, </FONT><A HREF="https://www.sec.gov/Archives/edgar/data/1901215/000121390025027989/ea0236829-6k_brenmiller.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    2, 2025</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">, </FONT><A HREF="https://www.sec.gov/Archives/edgar/data/1901215/000121390025043323/ea0242074-6k_brenmiller.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    14, 2025</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">, </FONT><A HREF="https://www.sec.gov/Archives/edgar/data/1901215/000121390025052346/ea0245088-6k_brenmiller.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    9, 2025</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">, </FONT><A HREF="https://www.sec.gov/Archives/edgar/data/1901215/000121390025054972/ea0245880-6k_brenmiller.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    17, 2025</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">, </FONT><A HREF="https://www.sec.gov/Archives/edgar/data/1901215/000121390025055868/ea0246313-6k_brenmiller.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    20, 2025</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">, </FONT><A HREF="https://www.sec.gov/Archives/edgar/data/1901215/000121390025068449/ea0250405-6k_brenmiller.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    29, 2025</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">, <A HREF="https://www.sec.gov/Archives/edgar/data/1901215/000121390025074347/ea025267301-6k_brenmiller.htm">August
    11, 2025</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/1901215/000121390025078589/ea0253765-6k_brenmiller.htm">August 19,
    2025</A>, <A HREF="https://www.sec.gov/Archives/edgar/data/1901215/000121390025079410/ea0253765-6k_brenmiller.htm">August 21, 2025</A>,
    <A HREF="https://www.sec.gov/Archives/edgar/data/1901215/000121390025091718/ea0258811-6k_brenmiller.htm">September 25, 2025</A>,
    <A HREF="https://www.sec.gov/Archives/edgar/data/1901215/000121390025093136/ea0259301-6k_brenmiller.htm">September 29, 2025</A>,
    <A HREF="http://www.sec.gov/Archives/edgar/data/1901215/000121390025093469/ea0254605-6k_brenmiller.htm">September 30, 2025</A>
    (excluding the second paragraph in the press release attached as Exhibit 99.1), and <A HREF="https://www.sec.gov/Archives/edgar/data/1901215/000121390025096527/ea026043501-6k_brenmiller.htm">October 6, 2025</A>;</FONT> </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The description of our securities contained in our </FONT><A HREF="https://www.sec.gov/Archives/edgar/data/1901215/000121390022027734/ea159877-8a12b_brenmiller.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form 8-A</FONT></A> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(File No. 001-40753), filed with the SEC on May 17, 2022, as amended by Exhibit 2.2 to the 2024 Annual Report, and including any further amendment or report filed or to be filed for the purpose of updating such description.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All subsequent annual reports
filed by us pursuant to the Exchange Act on Form 20-F prior to the termination of the offering shall be deemed to be incorporated by reference
to this prospectus and to be a part hereof from the date of filing of such documents. We may also incorporate part or all of any Form
6-K subsequently submitted by us to the SEC prior to the termination of the offering by identifying in such Forms 6-K that they, or certain
parts of their contents, are being incorporated by reference herein, and any Forms 6-K so identified shall be deemed to be incorporated
by reference in this prospectus and to be a part hereof from the date of submission of such documents. Any statement contained in a document
incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this prospectus
to the extent that a statement contained herein or in any other subsequently filed document which also is incorporated or deemed to be
incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed,
except as so modified or superseded, to constitute a part of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will provide you without
charge, upon your written or oral request, a copy of any of the documents incorporated by reference in this prospectus, other than exhibits
to such documents which are not specifically incorporated by reference into such documents. Please direct your written or telephone requests
to us at: Brenmiller Energy Ltd., 13 Amal Street, 4<SUP>th</SUP> Floor, Park Afek, Rosh Haayin, 4809249 Israel. Attention: Ofir Zimmerman,
Chief Financial Officer, telephone number: +972-77-693-5140.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="image_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>BRENMILLER ENERGY LTD.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>Up to 6,643,356 Ordinary
Shares</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.75in">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PART II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INFORMATION NOT REQUIRED IN PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 8. Indemnification of Directors, Officers
and Employees</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Indemnification</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Israeli Companies Law
5759-1999, or the Companies Law, and the Israeli Securities Law, 5728-1968, or the Securities Law, provide that a company may indemnify
an officeholder against the following liabilities and expenses incurred for acts performed by him or her as an officeholder, either pursuant
to an undertaking made in advance of an event or following an event, provided its articles of association include a provision authorizing
such indemnification:&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a financial liability imposed on him or her in favor of another person by any judgment concerning an act performed in his or her capacity as an officeholder, including a settlement or arbitrator&rsquo;s award approved by a court;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reasonable litigation expenses, including attorneys&rsquo; fees, expended by the officeholder (a) as a result of an investigation or proceeding instituted against him or her by an authority authorized to conduct such investigation or proceeding, provided that (1) no indictment (as defined in the Companies Law) was filed against such officeholder as a result of such investigation or proceeding; and (2) no financial liability as a substitute for the criminal proceeding (as defined in the Companies Law) was imposed upon him or her as a result of such investigation or proceeding, or, if such financial liability was imposed, it was imposed with respect to an offense that does not require proof of criminal intent; or (b) in connection with a monetary sanction;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reasonable litigation expenses, including attorneys&rsquo; fees, expended by the officeholder or imposed on him or her by a court: (1) in proceedings that the company institutes, or that another person institutes on the company&rsquo;s behalf, against him or her; (2) in criminal proceedings of which he or she was acquitted; or (3) as a result of a conviction for a crime that does not require proof of criminal intent;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">expenses incurred by an officeholder in connection with an Administrative Procedure under the Securities Law, including reasonable litigation expenses and reasonable attorneys&rsquo; fees. An &ldquo;Administrative Procedure&rdquo; is defined as a procedure pursuant to chapters H3 (Monetary Sanction by the Israeli Securities Authority), H4 (Administrative Enforcement Procedures of the Administrative Enforcement Committee) or I1 (Arrangement to prevent Procedures or Interruption of procedures subject to conditions) to the Securities Law; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any other liability or expense for which it is permitted and/or will be permitted to indemnify an officeholder.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Companies Law also permits
a company to undertake in advance to indemnify an officeholder, provided that if such indemnification relates to financial liability imposed
on him or her, as described above, then the undertaking should be limited and shall detail the following foreseen events and amount or
criterion:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to events that in the opinion of the board of directors can be foreseen based on the company&rsquo;s activities at the time that the undertaking to indemnify is made; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in amount or criterion determined by the board of directors, at the time of the giving of such undertaking to indemnify, to be reasonable under the circumstances.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Companies Law, exemption,
indemnification and insurance of officeholders must be approved by the compensation committee and the board of directors (and, with respect
to directors and the chief executive officer, by the shareholders). However, under regulations promulgated under the Companies Law, the
insurance of officeholders does not require shareholder approval and may be approved by only the compensation committee if the engagement
terms are determined in accordance with the company&rsquo;s compensation policy, which was approved by the shareholders by the same special
majority required to approve a compensation policy, provided that the insurance policy is on market terms and the insurance policy is
not likely to materially impact the company&rsquo;s profitability, assets or obligations. In addition, under regulations promulgated under
the Companies Law, the insurance of office holders of a company in which there is a controlling shareholder who is also an office holder,
a board approval is also required, subject to meeting the aforesaid conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December 5, 2024, the general
meeting of our shareholders approved granting an indemnification and exemption letters to our officeholders and directors as may be from
time to time, in the form previously approved by our shareholders. Indemnification letters, covering indemnification and insurance of
those liabilities imposed under the Companies Law and the Securities Law, as discussed above, were granted to each of our officeholders
and were approved for any future officeholders. All of the Company&rsquo;s directors and the officers have executed indemnification letters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The maximum indemnification
amount set forth in such letters to all of our officeholders is limited to an amount equal to the higher of (i): $5,000,000; and (ii)
25% of our total shareholders&rsquo; equity, neutralizing a provision made for such indemnification, as reflected in our most recent financial
statements (annual or quarterly) prior to the date on which the indemnity payment is made. The maximum amount set forth in such letters
is in addition to any amount paid (if paid) under insurance and/or by a third party pursuant to an indemnification arrangement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the opinion of the SEC,
indemnification of directors and officeholders for liabilities arising under the Securities Act, however, is against public policy and
therefore unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Exemption</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Companies Law, an
Israeli company may not exempt an officeholder from liability for a breach of his or her duty of loyalty, but may exempt in advance an
officeholder from his or her liability to the company, in whole or in part, for damages caused to the company as a result of a breach
of his or her duty of care (other than in relation to distributions), but only if a provision authorizing such exemption is included in
its articles of association. Our amended and restated articles of association provide that we may exempt, in whole or in part, any officeholder
from liability to us for damages caused to the company as a result of a breach of his or her duty of care. Subject to the aforesaid limitations,
under the indemnification agreements, we exempt and release our officeholders from any and all liability to us related to any breach by
them of their duty of care to us to the fullest extent permitted by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Exemption letters were granted
to each of our officeholders and were approved for any future officeholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Limitations</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Companies Law provides
that we may not exempt or indemnify an officeholder nor enter into an insurance contract that would provide coverage for any liability
incurred as a result of any of the following: (1) a breach by the officeholder of his or her duty of loyalty unless (in the case of indemnity
or insurance only, but not exemption) the officeholder acted in good faith and had a reasonable basis to believe that the act would not
prejudice us; (2) a breach by the officeholder of his or her duty of care if the breach was carried out intentionally or recklessly (as
opposed to merely negligently); (3) an act committed with the intention of making a personal profit unlawfully; or (4) any fine, monetary
sanction, penalty or forfeit levied against the officeholder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Companies Law, exemption,
indemnification and insurance of officeholders in a public company must be approved by the compensation committee and the board of directors
(and, with respect to directors and the chief executive officer, by the shareholders). However, under regulations promulgated under the
Companies Law, the insurance of office holders shall not require shareholder approval and may be approved by only the compensation committee,
if the engagement terms are determined in accordance with the company&rsquo;s compensation policy that was approved by the shareholders
by the same special majority required to approve a compensation policy, provided that the insurance policy is on market terms and the
insurance policy is not likely to materially impact the company&rsquo;s profitability, assets or obligations. In addition, under regulations
promulgated under the Companies Law, the insurance of office holders of a company in which there is a controlling shareholder who is also
an office holder, a board approval is also required, subject to meeting the aforesaid conditions.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our amended and restated articles
of association permit us to exempt (subject to the aforesaid limitation), indemnify and insure our officeholders to the fullest extent
permitted or to be permitted by the Companies Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 9. Exhibits</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; vertical-align: top; width: 8%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit <BR>
Number</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; vertical-align: bottom; width: 91%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit Description</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1901215/000121390025093136/ea025930101ex99-1_brenmiller.htm">Amended and Restated Articles of Association of Brenmiller Energy Ltd. (incorporated herein by reference to Exhibit 99.1 to our Report of Foreign Private Issuer on form 6-K (File No. 001-41402) filed with the SEC on September 29, 2025)</A>.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1901215/000121390025068449/ea025040501ex4-1_brenmiller.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Warrant (incorporated herein by reference to Exhibit 4.1 to our Report of Foreign Private Issuer on form 6-K (File No. 001-41402) filed with the SEC on July 29, 2025).</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1**</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1901215/000121390025094365/ea025912801ex5-1_brenmiller.htm"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion of Sullivan &amp; Worcester Tel Aviv (Har-Even &amp; Co.), Israeli counsel to Brenmiller Energy Ltd.</FONT> </A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1901215/000121390025068449/ea025040501ex10-1_brenmiller.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Securities Purchase Agreement, dated as of July 25, 2025, between the Company and the purchaser named in the signature page thereto (incorporated herein by reference to Exhibit 10.1 to our Report of Foreign Private Issuer on form 6-K (File No. 001-41402) filed with the SEC on July 29, 2025).</FONT></A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1901215/000121390025068449/ea025040501ex10-3_brenmiller.htm">Equity Closing Registration Rights Agreement, dated as of July 25, 2025, between the Company and the purchaser named in the signature page thereto (incorporated herein by reference to Exhibit 10.3 to our Report of Foreign Private Issuer on form 6-K (File No. 001-41402) filed with the SEC on July 29, 2025).</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U><A HREF="https://www.sec.gov/Archives/edgar/data/1901215/000121390025074347/ea025267301ex10-1_brenmil.htm">Amendment to the Securities Purchase Agreement, dated as of August 11, 2025, between the Company and the purchaser named on the signature page thereto (incorporated herein by reference to Exhibit 10.1 to our Report of Foreign Private Issuer on form 6-K (File No. 001-41402) filed with the SEC on August 11, 2025).</A></U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1*</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"> <A HREF="ea026415501ex23-1_brenmiller.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent
    of Kesselman &amp; Kesselman, a member firm of PricewaterhouseCoopers International Limited independent registered public accounting
    firm</FONT></A> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2**</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"> <A HREF="http://www.sec.gov/Archives/edgar/data/1901215/000121390025094365/ea025912801ex5-1_brenmiller.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent
    of Sullivan &amp; Worcester Tel Aviv (Har-Even &amp; Co.) (included in Exhibit 5.1).</FONT></A> </TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1**</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1901215/000121390025094365/ea0259128-f3_brenmiller.htm#p_001"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power of Attorney (included on signature page of the Registration Statement).</FONT> </A></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">107**</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"> &nbsp; </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1901215/000121390025094365/ea025912801ex-fee_brenmiller.htm"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Calculation of Filing Fee Tables.</FONT> </A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
herewith.</FONT></TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left"> ** </TD><TD STYLE="text-align: justify"> Previously filed </TD></TR>
     </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 10. Undertakings</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: justify">The undersigned Registrant hereby undertakes:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(1) To file, during any period
in which offers or sales are being made, a post-effective amendment to this registration statement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">(i)</TD><TD STYLE="text-align: justify">To include any prospectus required by section 10(a)(3) of the
Securities Act of 1933;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">(ii)</TD><TD STYLE="text-align: justify">To reflect in the prospectus any facts or events arising after
the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the
aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing,
any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which
was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus
filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change
in the maximum aggregate offering price set forth in the &ldquo;Calculation of Registration Fee&rdquo; table in the effective registration
statement.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">(iii)</TD><TD STYLE="text-align: justify">To include any material information with respect to the plan
of distribution not previously disclosed in the registration statement or any material change to such information in the registration
statement;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">provided, <I>however</I>, that paragraphs
(a)(1)(i), (a)(1)(ii) and a(l)(iii) do not apply if the registration statement is on Form S-3 or Form F-3 and the information required
to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the SEC by the registrant
pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration
statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(2) That, for the purpose
of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration
statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial
<I>bona fide</I> offering thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(3) To remove from registration
by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(4) To file a post-effective
amendment to the registration statement to include any financial statements required by Item 8.A. of Form 20-F at the start of any delayed
offering or throughout a continuous offering. Financial statements and information otherwise required by Section 10(a)(3) of the Act need
not be furnished, <I>provided</I>, that the registrant includes in the prospectus, by means of a post-effective amendment, financial statements
required pursuant to this paragraph (a)(4) and other information necessary to ensure that all other information in the prospectus is at
least as current as the date of those financial statements. Notwithstanding the foregoing, with respect to registration statements on
Form F-3, a post-effective amendment need not be filed to include financial statements and information required by Section 10(a)(3) of
the Act or Rule 3-19 of this chapter if such financial statements and information are contained in periodic reports filed with or furnished
to the Commission by the registrant pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 that are incorporated
by reference in the Form F-3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(5) That, for the purpose
of determining liability under the Securities Act to any purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.75in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the Registrant is relying on Rule 430B:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each prospectus filed by the Registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. <I>Provided, however,</I> that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(6) That, for the purpose
of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities
the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration
statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to
such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will
be considered to offer or sell such securities to such purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.75in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.75in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.75in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.75in">&nbsp;</TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(b) The undersigned registrant hereby undertakes
that, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant&rsquo;s annual report
pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan&rsquo;s
annual report pursuant to Section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration
statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities
at that time shall be deemed to be the initial bona fide offering thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(c) Insofar as indemnification for liabilities
arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the Registrant pursuant to
the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission
such indemnification is against public policy as expressed in the Securities Act of 1933 and is, therefore, unenforceable. In the event
that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a
director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by
such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion
of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether
such indemnification by it is against public policy as expressed in the Securities Act of 1933, as amended, and will be governed by the
final adjudication of such issue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="n_001"></A>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> Pursuant to the requirement
of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements
for filing on Form F-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly
authorized, the City of Rosh Haayin, State of Israel on November 5, 2025. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Brenmiller Energy Ltd.</B></FONT> </TD>
    <TD> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%"> &nbsp; </TD>
    <TD STYLE="width: 37%"> &nbsp; </TD>
    <TD STYLE="width: 60%"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 1.5pt solid"> &nbsp;/s/ <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Avraham
    Brenmiller</FONT> </TD>
    <TD> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Avraham Brenmiller</FONT> </TD>
    <TD> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT> </TD>
    <TD> &nbsp; </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; text-align: justify; margin: 0pt 0"> Pursuant to the requirements of the Securities Act of 1933, this
amendment to the registration statement on Form F-1 has been signed by the following persons in the capacities and on the dates indicated.&nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 25%"> <FONT STYLE="font-family: Times New Roman, Times, Serif; text-decoration: none"><B>Signature</B></FONT> </TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%"> &nbsp; </TD>
    <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid; width: 48%"> <FONT STYLE="font-family: Times New Roman, Times, Serif; text-decoration: none"><B>Title</B></FONT> </TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%"> &nbsp; </TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; width: 25%"> <FONT STYLE="font-family: Times New Roman, Times, Serif; text-decoration: none"><B>Date</B></FONT> </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;/s/ <FONT STYLE="font-size: 10pt">Avraham
    Brenmiller</FONT></FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">Chief Executive Officer, Director, Chairman of the Board of Directors</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">November 5, 2025</FONT> </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">Avraham Brenmiller</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">(Principal Executive Officer)</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;/s/ Ofir Zimmerman</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">Chief Financial Officer</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">November 5, 2025</FONT> </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">Ofir Zimmerman</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">(Principal Financial and Accounting Officer)</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif; text-decoration: none">*</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">Director</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">November 5, 2025</FONT> </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">Zvi Joseph</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif; text-decoration: none">*</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">Director</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">November 5, 2025</FONT> </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">Doron Brenmiller</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif; text-decoration: none">*</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">Director</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">November 5, 2025</FONT> </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">Boaz Toshav</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif; text-decoration: none">*</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">Director</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">November 5, 2025</FONT> </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">Nir Brenmiller</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif; text-decoration: none">*</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">Director</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">November 5, 2025</FONT> </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">Michael Korner</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif; text-decoration: none">*</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">Director</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">November 5, 2025</FONT> </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">Harel Gadot</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid"> /s/ Orna Ben Yosef </TD>
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif">Director</FONT> </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> <FONT STYLE="font-family: Times New Roman, Times, Serif">November 5, 2025</FONT> </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt"> Orna Ben Yosef </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 4%"> *By: </TD>
  <TD STYLE="border-bottom: Black 1.5pt solid; width: 36%"> &nbsp;/s/ Ofir Zimmerman </TD>
  <TD STYLE="width: 60%"> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD> Name:&nbsp; </TD>
  <TD> &nbsp;Ofir Zimmerman </TD>
  <TD> &nbsp; </TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD> Title: </TD>
  <TD> <I>Attorney-in-fact</I> </TD>
  <TD> &nbsp; </TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURE OF AUTHORIZED REPRESENTATIVE IN THE
UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> Pursuant to the Securities
Act of 1933, as amended, the undersigned, Brenmiller Energy U.S. Inc., the duly authorized representative in the United States of Brenmiller
Energy Ltd., has signed this registration statement on November 5, 2025. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Brenmiller Energy U.S. Inc.</B></FONT> </TD>
    <TD> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%"> &nbsp; </TD>
    <TD STYLE="width: 37%"> &nbsp; </TD>
    <TD STYLE="width: 60%"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:&nbsp;</FONT> </TD>
    <TD STYLE="border-bottom: black 1.5pt solid"> &nbsp;/s/<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
    Avraham Brenmiller</FONT> </TD>
    <TD> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Avraham Brenmiller</FONT> </TD>
    <TD> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD> &nbsp; </TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT> </TD>
    <TD> &nbsp; </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 29; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>2
<FILENAME>ea026415501ex23-1_brenmiller.htm
<DESCRIPTION>CONSENT OF KESSELMAN & KESSELMAN, A MEMBER FIRM OF PRICEWATERHOUSECOOPERS INTERNATIONAL LIMITED INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 23.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><IMG SRC="ex23-1_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.35pt 0pt 0in"><FONT STYLE="background-color: white">We hereby consent
to the incorporation by reference in this Registration Statement on Form F-3 of Brenmiller Energy Ltd. of our report dated March 4, 2025,
relating to the financial statements, which appears in Brenmiller Energy Ltd.'s Annual Report on Form 20-F for the year ended December&nbsp;31,
2024. We also consent to the reference to us under the heading &ldquo;Experts&rdquo; in such Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; font-size: 10pt">/s/ Kesselman &amp; Kesselman</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">Certified Public Accountants (Isr.)</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">A member of PricewaterhouseCoopers International Limited</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt">Tel-Aviv, Israel</P></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">November 5, 2025</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="ex23-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">Kesselman
&amp; Kesselman, 146 Derech Menachem Begin St. Tel-Aviv 6492103, Israel,<BR>
P.O Box 7187 Tel-Aviv 6107120, Telephone: +972 -3- 7954555, Fax:+972 -3- 7954556, www.pwc.com/il</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">Kesselman &amp; Kesselman is a member firm of PricewaterhouseCoopers
International Limited, each member firm of which is a separate legal entity</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !R 'H# 2(  A$! Q$!_\0
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M!_I=SP2OJ"3@'<1_NYSUS7-^$]$ATV$>,O%*FPLM/S=Z3;7)"^4-N3(1GCJ
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MG[/VJ_&GP'=ZKJ^KG4CI?]A2:!KFM:,2"R)_R(YRA1M^Q2=C.I_7WXS?#O\
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MW<6W[1FLV=I>:M>'47 7X9_#S&&!&!R2>1G Z &OV@_:,_Y->^.'_9"?B?\
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M@?#NL'4M-'_"Z?$91M<3JI?+ D\,(Q@$J<_3NA?LT>*A_P '#>KWI\.:]:^
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M<C&0#ZC-3]9DKWC:[OJY+=)V]WM_6MQ2RZ-_CC]Z5_/?KN?'_C;_ )-J^/\
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&?Y+\D?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !R 'H# 2(  A$! Q$!_\0
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MA'RD-C;7"_M-_ C2O JZ7\5/A/-L\"ZP1>O=6EX0-%U$Y*3+ZJP)'JK*057
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M%E_P31_X))ZM;^*?$5KJ.K>)?CM_;-[9ZOJXU34=OQ+51N*G<Q !"EP"!\H
M4+G._9W_ .47_P#P5^_[*)\#/_5GP51_:M_Y1=_\$@O^QF^/'X?\7)3_ /7^
M-1)1>+?NJWM)+9)->R3[>GYF2G/ZO3]Z5^9:W?\ T%KSOMOO=>1_9O\ M 2S
M/^S3\<)HYIH)Q\%?B>RW1 ^4KX*UUE;!)^96 *G (.#GI7XO?\&YNOZYKW[)
MWQFFUO6]2UNXMOVC-9L[2\U:\.HN OPS^'F,,",#DD\C.!T -?M!^T9_R:]\
M</\ LA/Q/_\ 5<:_7XG_ /!MIG_AD;XR9Z?\-':SU_[)G\//TQ7GTW'ZAF%^
M6_M*=MN;6<KV=K[6O\CZC$.7U_ ?%R\FMF[?#&U[:?>?&'_!2SX9:W^T/_P6
M@^&'[-H^)OCCX=:!\3?AKX$LKS5O"=ZI:RV:)X_UW']BNRJ6/]A$;G8#.-[
M9(^H_BU_P3<'[!G['7[:OQ+T/]HGXG_%+4/$_P "6\-"W\26JZ:-!;_A,M%U
MMM:@=/$CEI%*E'1O+949SN.TH?CS_@ICX<^.GB[_ (+<_"?PY^S=XSTKX?\
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-9/?Y+\D-[_)?DC__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>ex23-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex23-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 9 !D  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  T (H# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBBB@ H
MHHH **** "BBB@ HK\N?^"H'[6GC3]G[X9Z-X$^#HU^/XO\ Q+F:2SUW0-!O
M=9F\$>#M*N(FUC7P8M.U"RBU75+GRM!T6*[BDXGU345CW:8A;\$?^&W_ /@H
M1_T6#XW?^$7#_P#,97\\>)'TDN$/#;B6KPMC,AXKX@Q^%PN&Q&.K</X'#U\'
M@JN*C*K3P-6OBI4U/%QP_LL16A1]I"C'$4:=2:K2E3A_97@Q]";Q'\:.!\+Q
M]@.*.".$LHS+&X[#93AN*L9F-+,<SPN JK#5<VH8?+H552RZKC8XK"82>)]G
M5Q4L#BJ]*F\+&G5J_P!FE>&?M(_'CPK^S5\&O&GQ?\6D3VGAK3RND:,DR0W?
MB;Q-?M]D\/>&[!FR?M&K:G)#!)*J2_8K(7>HRQFWLYB/Y/3^W#_P4'4%F^,/
MQN  ))/@N+  &23CP9V'-?O7^RQ^S1XD^/?[.'A77/V]Y=5^-_B/Q9JT?Q!\
M,>$/B #9VWP[T:YTR2P\/P?V7HL6AJ/$.I:5=7&JZL^HI<7%A_:D6E(EK+9W
M7G<7"'CY4\6IYYP[X?\ "7$F2Y_1R+'8O"Y[Q?A,-A^',JQ,E'"X&MC_ *E.
MMC,3.6*KN6%P6&HU)XFKA;5O982.)JGJ^(/T1L/]'VGPOQIXQ>(/"7$/!]?B
MO*LOQW"OA]6S+$<9\1X.$IYAFF#R99M]4RS"4X8#"1CF.9XW%T*>!PF/<L-[
M?,JF7X=_GTO_  7+^+6U=_P ^'V_ W;?&'B,KNQ\VTG3,XSG&>U+_P /R_BQ
M_P!$ ^'_ /X5_B/_ .5E?KC_ ,.W?V&_^C;O '_?.M?_ "WH_P"';O[#?_1M
MW@#_ +YUK_Y;U\C_ ,0W^EK_ -'RX=_\-+_^A8^__P"(T?L]_P#I&'C+Y9A0
MM\O^-CGG?[ /[8GQC_;&MO&_BWQ3\*/"O@#X<>%I[?0-+UW2]:UK4[WQ)XO=
M8KS4-.L8KZSMK46&A:9+;OJET'=_MVI65I"I:*\,7Z0UPWPX^&G@+X0^#]*\
M ?#/PKI/@SP;HGVHZ7X?T6 P6-J]]=SW][*-[R333W5Y<SW%Q<7$LL\LLC,\
MAX [FOZ:X+ROB#)N&<IR_BKB"IQ1Q'1P[EG&=SHT<-3Q>-JU)U:D<+AZ&%PD
M*6"PRE3PV$C.A&O.E2=;$-UJTE3_ (>\3L_X/XFXYX@SC@#A"AP+P97Q4:7#
MG#-*MB,36P6686C3H4:V8XC$YAF<JV:X^4:V.S%TL7/"4J]>&&P<5A\+&=<H
MHHKZ@^""BBB@#Q/X]?M)?L__ ++7@:7XF?M'_&;X:_ _P%'="P3Q3\3O&&B>
M#]*O=3:WN+N/2-*FUF\M6UC6I[:UN9[71M*2\U2ZC@F:VM)?+;'XIZ1_P= _
M\$E?%O[2/P\_9J^'GQ7\<^/M5^(7BVV\()\6--\#KX4^!WA&YN)&1]9\7^._
MB=K?@2XM/#-G"DE[>^(-)T+6M,MK&*6X>X&P(WZ^_M3_ +)?[,W[77@.R\)_
MM/? [X<_';POX.O[WQ?X9\/_ !)\/V_B+2M&\2QZ+J.EKK-C;7!46]__ &=?
MWME]HB995M[F5492P8?XY7_!+OX3_#?XQ_\ !53]COX-?$_P=H_C3X6^//VK
M? _@SQ?X(UF*630]?\+:CXN%E>Z'?PPS0RO87%J?(DB69"T?REB"00#_ $1O
MB1_P=[?\$A?A]\1]?^'^GZE^T7\3-.\/ZY-H<GQ,^''PGT/4/ASJ[6TXMKK5
M?#]]XE^('A;Q/J^APS"7RM2A\*I'J4$)O-&74K*>SN+G]IO@[_P4J_87^.7[
M+$7[:?@G]ICX6V?[-*3IIVN_$_QSXEL?AWH_@OQ"9K*VD\)>.H_&\FA7/A#Q
M;%=ZEIUJOA_7(;34+R34--ETV*]M=3TZXNOY3_\ @Y?_ ."%?["/P=_X)]>+
M_P!LG]D_X(^$_P!G;XC_ +/?B#P'+XHTSX=)?:7X3^(G@#QQXST+X>WNG:OX
M8>YN=+A\0:'K/BC1=>TSQ#I\-C>/8V>L:?JK:C'=V4FG?F#_ ,&?-KX0^//Q
ME_;9_8E^._@3PC\9/V;_ (H? KPI\8_$7PK^(_A^R\8>"YO'WPL^)?AG0O#V
MN_V!K$5UI4%_]@\<W9FOUM5O9+C1] =)U.F6^P _K@\6_P#!S/\ \$=O#WQ.
M\+?"3P[^TKJ7Q6\5^+O$.B^%M,N?A3\,O'WBKPPFL^(-6AT33+>;Q9+H>F:!
M<1RW\\2O/I=]J,4<+I<,WDNCM^R/[0/QY^%G[+WP4^)G[0GQM\46W@SX5?"/
MPEJGC3QMXBNHY9S9:1I<0;R+*R@5[K4]8U2[>VTG0M'LHY=0UG6KZPTK3X9K
MV\@B?_(S_P""B_PA^&'P%_X+[?$GX0?!CP-X>^&OPP\"_ME?!72/!_@;PI9F
MP\/>'=.DN_AG?RV>EV1DE%M;RW]Y=W9A1O*2:YD$*11;(T_HY_X.K?VV_BG^
MU?XE^)'_  3F_96\W6?A1^Q?\/(?VH/V^O&-A>I!X>M-5LM3\/Z5\/OAMJ6I
MQ,\-S)X7U+Q=H&I7/AXM+)J_CWQ'H5K]GMKSX?:I-; ']6'_  3I_P""P7[%
M7_!4O4?BQI?[(_B;QWXAN_@M9>#;_P =KXR^'^M>"([2W\>3^);?P]_9\FK$
MKJ3S2>$]9%REOS:K% TG%PE?*VI_\''?_!.30/\ @H'J7_!.GQ+J7Q=\-_%7
M2_BR/@3<?$76? =A;_!W_A;3ZM'X>A\+'7H?$T_BB"VN?$DT'AR#Q'=^#K?0
M/[5D$T]]!H.W6V_G'_X,<Y$B\7_\%(Y972../PM^R])))(P1(T34_CRSN[L0
MJHJ@LS,0% )) %?)_P"R#^P%9_\ !3#_ (+]_MN_M@:?JJ:[^PQ^RG^V'\2_
MVBO'OQ7\/;[WP]\1KSP=XYU?QI\/OASX(U,".UUN?QAJ&@0ZQK-U9S-;6G@&
MTOKX7,5UK?AK^T0#^^_]MS_@I/\ L3_\$Z_">G>*_P!KKX\^%/A8=>ANI_"O
MA)UO_$?Q#\8QV;".ZE\*^ /#5IJOBO5[.VF9(+O58=+71[*XDB@O=1MY9HD?
M\=%_X.S_ /@EI!%H^O:YX9_;'\+_  Q\1ZMJ.B>&?C5K_P"SA>P?"SQ+J6C_
M &<ZO::!K%CXKO\ 7-4NM*2YADU*QM?#KZA91NAN;2,RPK)_GQ7OQ?\ 'G_!
M8S_@L#\,O$O[0?B+5-6MOVJ_VM_AAX!N-/FU*>"W\#_!CQ+\3=*T'2_A]X1$
MKS)HVE^$_ E[)I>C6\ W3ZD)M4OI+K5]3U"^N?[Y_P#@XM_X(N_'[]O_ /9Q
M_8T^$7[!/A'X/>&M"_9;U_QM:1_#'5=>M_AKI&G^#O$7AOPCH?AZS\%(FDS>
M'H[?0_\ A&IH[VQO+K3)#!=036CWDPN(R ?T8?LT_M-_ K]L'X,^#_V@?V;_
M (CZ%\5/A)XZM[J;P_XLT%KF.)KC3[N;3]5TG5--U"WL]6T/7='U"WGL-7T/
M6;&QU33KJ)HKJUCRA;W>OPU_X-[?^"<OQU_X)A_\$_E_9^_:,UCPA?\ Q/\
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,H **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>ex23-1_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex23-1_002.jpg
M_]C_X  02D9)1@ ! 0$       #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  . L,# 2(  A$! Q$!_\0
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M+H\#VSZ9IVCM$9;K!TW2+I;W3K3(G#;+6Z19E;=YCL )7=?EKJZ*'EV7M-/
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MTR)[D:Q9^(!*9;@$:Q86KV-G?!1,$\R"UD>%4V^2RL2\;/AJZ&BDLNR^-N7
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&8QC_ /_9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
